What is the projected market valuation for the GCC ventricular assist-devices market in 2035?

The projected market valuation for the GCC ventricular assist-devices market in 2035 is $200.0 Million. Read More

What was the overall market valuation in 2024?

The overall market valuation in 2024 was $68.25 Million. Read More

What is the expected CAGR for the GCC ventricular assist-devices market during the forecast period 2025 - 2035?

The expected CAGR for the GCC ventricular assist-devices market during the forecast period 2025 - 2035 is 10.27%. Read More

Which companies are considered key players in the GCC ventricular assist-devices market?

Key players in the GCC ventricular assist-devices market include Abbott, Medtronic, Boston Scientific, Terumo, Cleveland Heart, ReliantHeart, Syncardia, Getinge, and CardiacAssist. Read More

What are the different product types available in the GCC ventricular assist-devices market?

The product types available in the GCC ventricular assist-devices market include Left Ventricular Assist Device (LVAD), Right Ventricular Assist Device (RVAD), and Biventricular Assist Device (BIVAD). Read More

What is the valuation range for Left Ventricular Assist Devices (LVAD) in the market?

The valuation range for Left Ventricular Assist Devices (LVAD) in the market is between $30.0 Million and $90.0 Million. Read More

What types of flow are present in the GCC ventricular assist-devices market?

The types of flow present in the GCC ventricular assist-devices market are Continuous Flow and Pulsatile Flow. Read More

What is the projected valuation for Continuous Flow devices in the market?

The projected valuation for Continuous Flow devices in the market ranges from $40.0 Million to $115.0 Million. Read More

What applications are served by ventricular assist-devices in the GCC market?

The applications served by ventricular assist-devices in the GCC market include Destination Therapy and Bridging Therapy. Read More

What is the valuation range for Bridging Therapy in the GCC ventricular assist-devices market?

The valuation range for Bridging Therapy in the GCC ventricular assist-devices market is between $38.25 Million and $110.0 Million. Read More

GCC Ventricular Assist Devices Market

GCC Ventricular Assist Devices Market Research Report: Size, Share, Trend Analysis By Product Type (Left Ventricular Assist Device, Right Ventricular Assist Device, Biventricular Assist Device), By Types of Flow (Continuous Flow, Pulsatile Flow), By Design (Implantable Ventricular Assist Device, Transcutaneous Ventricular Assist Device) and By Applications (Destination Therapy, Bridging Therapy) - Growth Outlook & Industry Forecast 2025 To 2035

Forecast Period

2025 - 2035

CAGR

10.27%

2024 Market Size

$ 68.25 Million

2035 Market Size

$ 200 Million

Healthcare ● Updated April 2026 Report ID: MRFR/HC/49952-HCR | Pages: 200 | Author: Rahul Gotadki

Summary Table of Contents Segmentation Download PDF

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Life Sciences, BY Product Type (USD Million)
  1. 4.1.1 Left Ventricular Assist Device (LVAD)
  2. 4.1.2 Right Ventricular Assist Device (RVAD)
  3. 4.1.3 Biventricular Assist Device (BIVAD)
2. 4.2 Life Sciences, BY Type of Flow (USD Million)
  1. 4.2.1 Continuous Flow
  2. 4.2.2 Pulsatile Flow
3. 4.3 Life Sciences, BY Design (USD Million)
  1. 4.3.1 Implantable Ventricular Assist Device
  2. 4.3.2 Transcutaneous Ventricular Assist Device
4. 4.4 Life Sciences, BY Application (USD Million)
  1. 4.4.1 Destination Therapy
  2. 4.4.2 Bridging Therapy
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Life Sciences
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Life Sciences
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Abbott (US)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Medtronic (US)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Boston Scientific (US)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Terumo (JP)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Cleveland Heart (US)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 ReliantHeart (US)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Syncardia (US)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Getinge (SE)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
  9. 5.2.9 CardiacAssist (US)
    1. 5.2.9.1 Financial Overview
    2. 5.2.9.2 Products Offered
    3. 5.2.9.3 Key Developments
    4. 5.2.9.4 SWOT Analysis
    5. 5.2.9.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 GCC MARKET ANALYSIS BY PRODUCT TYPE
3. 6.3 GCC MARKET ANALYSIS BY TYPE OF FLOW
4. 6.4 GCC MARKET ANALYSIS BY DESIGN
5. 6.5 GCC MARKET ANALYSIS BY APPLICATION
6. 6.6 KEY BUYING CRITERIA OF LIFE SCIENCES
7. 6.7 RESEARCH PROCESS OF MRFR
8. 6.8 DRO ANALYSIS OF LIFE SCIENCES
9. 6.9 DRIVERS IMPACT ANALYSIS: LIFE SCIENCES
10. 6.10 RESTRAINTS IMPACT ANALYSIS: LIFE SCIENCES
11. 6.11 SUPPLY / VALUE CHAIN: LIFE SCIENCES
12. 6.12 LIFE SCIENCES, BY PRODUCT TYPE, 2024 (% SHARE)
13. 6.13 LIFE SCIENCES, BY PRODUCT TYPE, 2024 TO 2035 (USD Million)
14. 6.14 LIFE SCIENCES, BY TYPE OF FLOW, 2024 (% SHARE)
15. 6.15 LIFE SCIENCES, BY TYPE OF FLOW, 2024 TO 2035 (USD Million)
16. 6.16 LIFE SCIENCES, BY DESIGN, 2024 (% SHARE)
17. 6.17 LIFE SCIENCES, BY DESIGN, 2024 TO 2035 (USD Million)
18. 6.18 LIFE SCIENCES, BY APPLICATION, 2024 (% SHARE)
19. 6.19 LIFE SCIENCES, BY APPLICATION, 2024 TO 2035 (USD Million)
20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 GCC MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY PRODUCT TYPE, 2025-2035 (USD Million)
  2. 7.2.2 BY TYPE OF FLOW, 2025-2035 (USD Million)
  3. 7.2.3 BY DESIGN, 2025-2035 (USD Million)
  4. 7.2.4 BY APPLICATION, 2025-2035 (USD Million)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

GCC Ventricular Assist Devices Market Segmentation

GCC Ventricular Assist Devices Market By Product Type (USD Million, 2025-2035)

Left Ventricular Assist Device (LVAD)
Right Ventricular Assist Device (RVAD)
Biventricular Assist Device (BIVAD)

GCC Ventricular Assist Devices Market By Type of Flow (USD Million, 2025-2035)

Continuous Flow
Pulsatile Flow

GCC Ventricular Assist Devices Market By Design (USD Million, 2025-2035)

Implantable Ventricular Assist Device
Transcutaneous Ventricular Assist Device

GCC Ventricular Assist Devices Market By Application (USD Million, 2025-2035)

Destination Therapy
Bridging Therapy

Certified Researchers

Customize Report

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”

Rob Kooiker Group Product Manager HVAC & Fire Protection GMA

“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”

Akif Moroglu Strategy & Business Development Director

“The Automotive 48V ECU Components Procurement Intelligence Study” was a complex project, but the Market Research Future (MRFR) team handled it with quality, agility, and customer-centricity. They delivered all requested data on time and within the agreed scope. The team, including Shubhendra Anand and Rahul Gotadki, was always readily available to clarify questions and swiftly implement necessary adjustments, driving the project to a successful conclusion within a very demanding timeframe.
I would also like to specifically commend Akshay Agarwal for his responsiveness and support at every stage—from our initial inquiry on May 6th through to final delivery on June 18th. His dedication made the entire process seamless.”